90 related articles for article (PubMed ID: 1860423)
1. [Insulin-induced edema in adolescents with type 1 diabetes mellitus].
Saule H
Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1191-4. PubMed ID: 1860423
[TBL] [Abstract][Full Text] [Related]
2. [Generalized edema following insulin treatment of newly diagnosed diabetes mellitus].
Júlíusson PB; Bjerknes R; Søvik O; Kvistad PH
Tidsskr Nor Laegeforen; 2001 Mar; 121(8):919-20. PubMed ID: 11332378
[TBL] [Abstract][Full Text] [Related]
3. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
4. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
[TBL] [Abstract][Full Text] [Related]
5. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
6. [Insulin edema in three adolescents with insulin-dependent diabetes mellitus].
Cotellessa M; Mazzella M; Mulas R; Caratozzolo A; Romano C
Minerva Pediatr; 1995 Jun; 47(6):245-8. PubMed ID: 7476751
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
Talaulicar M; Willms B
Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
[TBL] [Abstract][Full Text] [Related]
8. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up].
Krochik AG; Mazza CS; Araujo MB; Kovalskys I; Ozuna B; Assad D; Coppola L; Domenech I; Lahera E; Zufriategui Z; Gagliardino JJ
Medicina (B Aires); 2004; 64(2):107-12. PubMed ID: 15628295
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
11. Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetes.
Golden MP; Myers GL; Tanner SM; Marrero DG; Charles MA
Pediatrics; 1982 Jul; 70(1):36-42. PubMed ID: 7088631
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control.
Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2010 Jun; 33(6):e81. PubMed ID: 20508226
[No Abstract] [Full Text] [Related]
13. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced oedema in children and adolescents.
Mamoulakis D; Bitsori M; Galanakis E; Raissaki M; Kalmanti M
J Paediatr Child Health; 2006 Oct; 42(10):655-7. PubMed ID: 16972977
[TBL] [Abstract][Full Text] [Related]
15. [Successful insulin therapy in lipoatrophic diabetes].
Böhmer K; Hauner H; Phlippen R; Gries FA
Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
[TBL] [Abstract][Full Text] [Related]
16. Physiological insulin replacement in type 1 diabetes mellitus.
Bolli GB
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S317-32. PubMed ID: 11460580
[TBL] [Abstract][Full Text] [Related]
17. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T
Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561
[TBL] [Abstract][Full Text] [Related]
18. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
19. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
20. Long-term improvement in metabolic control of unstable type I diabetes by s.c. insulin injection patterns based on the dose profiles required by bed-side artificial beta-cell.
Bombor H; Bruns W; Ratzmann KP; Jutzi E; Albrecht G; Michaelis D; Fischer U
Exp Clin Endocrinol; 1984 Apr; 83(2):143-51. PubMed ID: 6373316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
